Codonopsis
Cancer-related Fatigue
Zhejiang Provincial People's HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Cancer-related Fatigue cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide PhytoHealth Corporation | Phase 2 | B |
Epirubicin PhytoHealth Corporation | Phase 2 | B |
ASTRAGALUS MEMBRANACEUS ROOT POLYSACCHARIDES PhytoHealth Corporation | Phase 2 | B |
pg2 lyo. PhytoHealth Corporation | Phase 2 | CCC |
Zhengyuan Capsules Qiang Fu | Phase 4 | NR |
Same molecule, other indications
Codonopsis is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →